Equine immunology 3: immunopharmacology--anti-inflammatory and antihypersensitivity drugs.
This article reviews anti-inflammatory and antihypersensitivity drugs under these 4 headings: Functional or physiological antagonists; Selective pharmacological inhibitors; Broad spectrum anti-inflammatory drugs; Miscellaneous inhibitors. The compounds considered include sympathomimetic amines, anticholinergic drugs, antihistamine drugs, tryptamine antagonists and dopamine antagonists, glucocorticosteroids and non-steroidal anti-inflammatory drugs, disodium cromoglycate and diethylcarbamazine citrate. The relationship of the pharmacological actions of these compounds is considered in the context of clinical conditions. The potential for immunomodulatory pharmacology is discussed using levamisole as an example.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D004205:Cromolyn Sodium / Q000494:pharmacology; D004049:Diethylcarbamazine / Q000031:analogs & derivatives / Q000494:pharmacology; D018492:Dopamine Antagonists; D005938:Glucocorticoids / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006736:Horses / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007978:Levamisole / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology; D014363:Tryptamines / Q000037:antagonists & inhibitors
D000893:Anti-Inflammatory Agents; D018492:Dopamine Antagonists; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D007166:Immunosuppressive Agents; D010276:Parasympatholytics; D013566:Sympathomimetics; D014363:Tryptamines; D007978:Levamisole; C030820:tryptamine; D004205:Cromolyn Sodium; D004049:Diethylcarbamazine